RU2033169C1 - Process for manufacture of complex including superoxide dis-mutase and catalase from human blood erythrocytes - Google Patents
Process for manufacture of complex including superoxide dis-mutase and catalase from human blood erythrocytes Download PDFInfo
- Publication number
- RU2033169C1 RU2033169C1 SU4696378A RU2033169C1 RU 2033169 C1 RU2033169 C1 RU 2033169C1 SU 4696378 A SU4696378 A SU 4696378A RU 2033169 C1 RU2033169 C1 RU 2033169C1
- Authority
- RU
- Russia
- Prior art keywords
- lysate
- catalase
- mutase
- during
- centrifuging
- Prior art date
Links
- 210000003743 erythrocyte Anatomy 0.000 title claims abstract description 12
- 102000016938 Catalase Human genes 0.000 title claims abstract description 8
- 108010053835 Catalase Proteins 0.000 title claims abstract description 8
- 102000019197 Superoxide Dismutase Human genes 0.000 title claims abstract description 7
- 108010012715 Superoxide dismutase Proteins 0.000 title claims abstract description 7
- 238000004519 manufacturing process Methods 0.000 title claims abstract 3
- 238000000034 method Methods 0.000 title abstract description 7
- 229940032362 superoxide dismutase Drugs 0.000 title abstract 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims abstract description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000006166 lysate Substances 0.000 claims abstract description 11
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims abstract description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000000047 product Substances 0.000 claims abstract description 8
- 239000006228 supernatant Substances 0.000 claims abstract description 8
- 239000012153 distilled water Substances 0.000 claims abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 5
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000004202 carbamide Substances 0.000 claims abstract description 4
- 239000000243 solution Substances 0.000 claims abstract 2
- 238000005406 washing Methods 0.000 claims abstract 2
- 238000003756 stirring Methods 0.000 claims description 4
- 239000013049 sediment Substances 0.000 claims 2
- 210000004369 blood Anatomy 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 239000002504 physiological saline solution Substances 0.000 claims 1
- 238000000746 purification Methods 0.000 claims 1
- 239000002244 precipitate Substances 0.000 abstract description 12
- 239000008363 phosphate buffer Substances 0.000 abstract description 5
- 238000000502 dialysis Methods 0.000 abstract description 3
- 230000000694 effects Effects 0.000 abstract description 3
- 238000001914 filtration Methods 0.000 abstract description 3
- 230000001954 sterilising effect Effects 0.000 abstract description 3
- 239000012535 impurity Substances 0.000 abstract description 2
- 239000007795 chemical reaction product Substances 0.000 abstract 3
- 239000007788 liquid Substances 0.000 abstract 2
- 230000002934 lysing effect Effects 0.000 abstract 1
- 239000008055 phosphate buffer solution Substances 0.000 abstract 1
- 239000012266 salt solution Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- -1 copper acetic acid zinc Chemical compound 0.000 description 1
- OPQARKPSCNTWTJ-UHFFFAOYSA-L copper(ii) acetate Chemical compound [Cu+2].CC([O-])=O.CC([O-])=O OPQARKPSCNTWTJ-UHFFFAOYSA-L 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000010198 maturation time Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 239000004246 zinc acetate Substances 0.000 description 1
Landscapes
- Enzymes And Modification Thereof (AREA)
Abstract
Description
Изобретение относится к медицинской биохимии, в частности к энзимологии. The invention relates to medical biochemistry, in particular to enzymology.
Целью изобретения является интенсификация способа. The aim of the invention is the intensification of the method.
Способ осуществляется следующим образом. The method is as follows.
5 л эритроцитов крови человека отмывают 0,85-1,0%-ным раствором хлористого натрия, центрифугируют при 2500g в течение 15 мин, лизируют эритроциты равным объемом дистиллированной воды в течение 4 ч при температуре 4оС. В лизат добавляют ионы Cu+2 и Zn+2 (из расчета 50 мг уксуснокислой меди и 200 мг уксуснокислого цинка на 1 л смеси). Для стабилизации фермента каталазы в смесь добавляют 0,3-0,5% мочевины по объему, тщательно размешивают в течение 15 мин. Затем лизат эритроцитов обрабатывают смесью хлороформа и этанола, охлажденных при минус 20оС, в соотношении лизат-хлороформ-этанол 1:0,15:0,25 при непрерывном помешивании в течение 40-60 мин. Центрифугируют при 2500g, удаляют осадок гемоглобина. К надосадочной жидкости добавляют 0,1 н.раствора соляной кислоты до рН 3,7-4,2. Осадок формируют в течение 10-12 ч, повторно центрифугируют. К полученной надосадочной жидкости, содержащей целевой продукт, добавляют ацетон в соотношении 1:1 при температуре минус 4оС. Время созревания осадка 2 ч. Далее центрифугируют при 2500g в течение 20 мин. Осадок растворяют в 80-100 мл KNa-фосфатном буфере с рН 7,4-7,8. Затем проводят диализ против 0,15 М фосфатного буфера с последующей стерилизующей фильтрацией целевого продукта через пластины ЕК.5 l of human blood erythrocytes washed 0.85-1.0% solution of sodium chloride, centrifuged at 2500g for 15 min, lysed erythrocytes with an equal volume of distilled water for 4 hours at 4 ° C. The lysate was added ions Cu + 2 and Zn +2 (based on 50 mg of copper acetate and 200 mg of zinc acetate per 1 liter of mixture). To stabilize the catalase enzyme, 0.3-0.5% urea by volume is added to the mixture, stir thoroughly for 15 minutes. Then the lysate of erythrocytes treated with a mixture of chloroform and ethanol, cooled at -20 ° C, in a ratio of lysate-chloroform-ethanol 1: 0.15: 0.25 under stirring for 40-60 min. Centrifuged at 2500g, remove the hemoglobin precipitate. To the supernatant add 0.1 N. a solution of hydrochloric acid to a pH of 3.7-4.2. The precipitate is formed within 10-12 hours, re-centrifuged. To the resulting supernatant containing the desired product were added acetone in a ratio of 1: 1 at a temperature of minus 4 ° C. The precipitate maturation time 2 h further centrifuged at 2500g for 20 min.. The precipitate was dissolved in 80-100 ml of KNa-phosphate buffer with a pH of 7.4-7.8. Then dialysis against 0.15 M phosphate buffer followed by sterilizing filtration of the target product through EC plates.
Целевой продукт содержит 1 фракцию каталазы и 2 фракции супероксиддисмутазы. Электрофоретическая чистота 99% содержание супероксиддисмутазы 33,3% каталазы 66,6% примесей 0,1% Удельная активность супероксиддисмутазы 2500-3000 ед. на 1 мг белка, каталазы 30000-40000 ед. активности на мг белка. The target product contains 1 fraction of catalase and 2 fractions of superoxide dismutase. Electrophoretic purity 99% superoxide dismutase content 33.3% catalase 66.6% impurities 0.1% Specific superoxide dismutase activity 2500-3000 units per 1 mg of protein, catalase 30000-40000 units. activity per mg protein.
П р и м е р. 5 л эритроцитов крови человека отмывают 0,85%-ным раствором хлористого натрия, центрифугируют при 2500g в течение 15 мин. Затем лизируют эритроциты равным объемом дистиллированной воды (5 л) в течение 4 ч при 4оС. В лизат добавляют 500 мг уксусно-кислой меди и 2 г уксусно-кислого цинка. Затем в лизат вносят навеску мочевины 50 г, тщательно размешивают 15 мин. В смесь (10 л) добавляют 2,5 л спирта и 1,5 л хлороформа, охлажденных до -20оС при непрерывном перемешивании в течение 40 мин. Затем центрифугируют при 2500g, удаляют осадок. В супернатанте устанавливают рН 0,1 н. раствором соляной кислоты до рН 4,0. Формируют осадок в течение 11 ч. Сформировавшийся осадок удаляют центрифугированием при 2500g. Из полученной надосадочной жидкости (7,5 л) осаждают комплекс ферментов охлажденным ацетоном в количестве 7,5 л. Осадок созревает 2 ч. Повторно центрифугируют при 2500g в течение 20 мин. Осадок растворяют в 100 мл КNa-фосфатном буфере. Далее проводят диализ против 0,15 М фосфатного буфера с последующей стерилизующей фильтрацией целевого продукта.PRI me R. 5 l of human red blood cells are washed with 0.85% sodium chloride solution, centrifuged at 2500g for 15 minutes. Then lysed erythrocytes with an equal volume of distilled water (5 l) for 4 hours at 4 ° C. The lysate was added 500 mg of acetic acid and 2 g of copper acetic acid zinc. Then 50 g of urea is weighed into the lysate, thoroughly stirred for 15 minutes. The mixture (10 l) was added 2.5 liters of alcohol and 1.5 L of chloroform cooled to -20 ° C under continuous stirring for 40 min. Then centrifuged at 2500g, remove the precipitate. The supernatant is adjusted to pH 0.1 N. hydrochloric acid solution to pH 4.0. A precipitate is formed for 11 hours. The formed precipitate is removed by centrifugation at 2500g. From the obtained supernatant (7.5 L), a complex of enzymes precipitated with chilled acetone in an amount of 7.5 L. The precipitate matures for 2 hours. Re-centrifuged at 2500g for 20 minutes. The precipitate was dissolved in 100 ml KNa-phosphate buffer. Then dialysis against 0.15 M phosphate buffer followed by sterilizing filtration of the target product.
Предложенный способ позволяет ускорить процесс получения целевого пpодукта по сравнению с прототипом с 50-56 до 26-36 ч. The proposed method allows to accelerate the process of obtaining the target product in comparison with the prototype from 50-56 to 26-36 hours
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU4696378 RU2033169C1 (en) | 1989-06-07 | 1989-06-07 | Process for manufacture of complex including superoxide dis-mutase and catalase from human blood erythrocytes |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU4696378 RU2033169C1 (en) | 1989-06-07 | 1989-06-07 | Process for manufacture of complex including superoxide dis-mutase and catalase from human blood erythrocytes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2033169C1 true RU2033169C1 (en) | 1995-04-20 |
Family
ID=21449968
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU4696378 RU2033169C1 (en) | 1989-06-07 | 1989-06-07 | Process for manufacture of complex including superoxide dis-mutase and catalase from human blood erythrocytes |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2033169C1 (en) |
-
1989
- 1989-06-07 RU SU4696378 patent/RU2033169C1/en active
Non-Patent Citations (1)
| Title |
|---|
| Misako Miyata - Asaneb et al, "Purification of copper - Linc - Super - oxide dismutase and catalase from human erythrocyties by copper - chellate affinity chromatography, J.Chromatography, v.370, N 3, 1986, p.501-507. * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SU1607689A3 (en) | Versions of method of activation of tissue activator of plasminogen | |
| US4439357A (en) | Process for obtaining hepatitis-safe, sterile hemoglobin solutions free of pyrogens and stroma | |
| KR940005589B1 (en) | Method for removal of nucleic acids and/or endotoxin | |
| Yamanaka et al. | Studies on Cytochrome C: III. Determination OF “Native” Mammalian Heart Muscle Cytochrome C and its Physiological Properties | |
| WO2008062998A1 (en) | Method for purifying hyaluronic acid | |
| JPS59137417A (en) | Preparation of colonization stimulation factor and kallikrein originated from human urine | |
| US4435506A (en) | Isolation of superoxide dismutase | |
| US4346174A (en) | Process for isolating superoxide dismutase from red blood cells | |
| RU2033169C1 (en) | Process for manufacture of complex including superoxide dis-mutase and catalase from human blood erythrocytes | |
| CN112159486B (en) | Method for preparing crude heparin sodium by utilizing low salt of small intestine mucosa of pig | |
| KR102580940B1 (en) | Extraction Method of high purity Poly Deoxy Ribo Nucleotide from meats of Salmonid fish | |
| US3597323A (en) | Method of purifying l-asparaginase | |
| RU2108797C1 (en) | Method of dna-base antiviral preparation preparing | |
| US3677901A (en) | Process for the production of glycerokinase | |
| US20050159593A1 (en) | Method for deproteinization of chitosan | |
| US4394450A (en) | Method for purification of uricase | |
| RU2033170C1 (en) | Method for production of catalase from erythrocytes of human blood | |
| US3477912A (en) | Method of production of urokinase | |
| CN1020734C (en) | Method for extracting superoxide-dismutase | |
| CN119073478B (en) | Bioactive peptide composite beverage and preparation method thereof | |
| CN117126821B (en) | Separation and extraction method of bovine blood Cu-Zn superoxide dismutase | |
| JPS589686A (en) | Purifying method of superoxide dismutase | |
| JP2757321B2 (en) | Purification method of ellagic acid | |
| CN119524019B (en) | Placenta lipopolysaccharide preparation and preparation method thereof | |
| US3016337A (en) | Process for depyrogenation and purification of streptokinase |